-
C3 Pharmaceuticals Announces IPO Plans On Canadian Exchange, Funding For Cannabis Tablet As SEC Battle Continues
Wednesday, September 18, 2024 - 4:53pm | 376Cannabinoid-focused biopharmaceutical company C3 Pharmaceuticals, Inc. announced Wednesday that it has executed a tailored share subscription agreement with GEM Global Yield LLC SCS and is planning on listing on the Canadian Securities Exchange. The California company said it has a commitment of...